BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22113576)

  • 21. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.
    Lan Q; Zheng T; Rothman N; Zhang Y; Wang SS; Shen M; Berndt SI; Zahm SH; Holford TR; Leaderer B; Yeager M; Welch R; Boyle P; Zhang B; Zou K; Zhu Y; Chanock S
    Blood; 2006 May; 107(10):4101-8. PubMed ID: 16449530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vegetable and fruit intake and non-Hodgkin lymphoma survival in Connecticut women.
    Han X; Zheng T; Foss F; Holford TR; Ma S; Zhao P; Dai M; Kim C; Zhang Y; Bai Y; Zhang Y
    Leuk Lymphoma; 2010 Jun; 51(6):1047-54. PubMed ID: 20350273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course.
    Pamuk GE; Tozkir H; Uyanik MS; Gurkan H; Duymaz J; Pamuk ON
    Leuk Lymphoma; 2015; 56(10):2902-7. PubMed ID: 25699652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma.
    Skibola DR; Smith MT; Bracci PM; Hubbard AE; Agana L; Chi S; Holly EA
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1251-6. PubMed ID: 15894681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.
    Lee KM; Lan Q; Kricker A; Purdue MP; Grulich AE; Vajdic CM; Turner J; Whitby D; Kang D; Chanock S; Rothman N; Armstrong BK
    Hum Genet; 2007 Dec; 122(5):525-33. PubMed ID: 17891500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A polymorphism at the microRNA binding site in the 3' untranslated region of C14orf101 is associated with non-Hodgkin lymphoma overall survival.
    Yang B; Liu C; Diao L; Wang C; Guo Z
    Cancer Genet; 2014 Apr; 207(4):141-6. PubMed ID: 24831772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occupational solvent exposure, genetic variation in immune genes, and the risk for non-Hodgkin lymphoma.
    Deng Q; Zheng T; Lan Q; Lan Y; Holford T; Chen Y; Dai M; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
    Eur J Cancer Prev; 2013 Jan; 22(1):77-82. PubMed ID: 22609637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body mass index, weight change, and survival in non-Hodgkin lymphoma patients in Connecticut women.
    Han X; Stevens J; Bradshaw PT
    Nutr Cancer; 2013; 65(1):43-50. PubMed ID: 23368912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
    Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
    Song H; Tong D; Cha Z; Bai J
    Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma.
    Gustafson HL; Yao S; Goldman BH; Lee K; Spier CM; LeBlanc ML; Rimsza LM; Cerhan JR; Habermann TM; Link BK; Maurer MJ; Slager SL; Persky DO; Miller TP; Fisher RI; Ambrosone CB; Briehl MM
    Am J Hematol; 2014 Jun; 89(6):639-45. PubMed ID: 24633940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequence polymorphisms in the D-loop region of mitochondrial DNA and outcome of non-Hodgkin lymphoma.
    Diao L; Wei G; Su H; Li H; Song J; Gao Y; Guo Z
    Mitochondrial DNA; 2015 Feb; 26(1):88-91. PubMed ID: 24021008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
    Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
    Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival patterns among lymphoma patients with a family history of lymphoma.
    Anderson LA; Pfeiffer RM; Rapkin JS; Gridley G; Mellemkjaer L; Hemminki K; Björkholm M; Caporaso NE; Landgren O
    J Clin Oncol; 2008 Oct; 26(30):4958-65. PubMed ID: 18606984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional factors and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort.
    Leo QJ; Ollberding NJ; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L; Maskarinec G
    Eur J Clin Nutr; 2016 Jan; 70(1):41-6. PubMed ID: 26330148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.
    Lee JJ; Kim DH; Lee NY; Sohn SK; Kim JG; Kim HJ; Do YR; Park YH
    Br J Haematol; 2007 May; 137(4):329-36. PubMed ID: 17408400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma.
    Drake MT; Maurer MJ; Link BK; Habermann TM; Ansell SM; Micallef IN; Kelly JL; Macon WR; Nowakowski GS; Inwards DJ; Johnston PB; Singh RJ; Allmer C; Slager SL; Weiner GJ; Witzig TE; Cerhan JR
    J Clin Oncol; 2010 Sep; 28(27):4191-8. PubMed ID: 20713849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
    Skibola CF; Bracci PM; Halperin E; Nieters A; Hubbard A; Paynter RA; Skibola DR; Agana L; Becker N; Tressler P; Forrest MS; Sankararaman S; Conde L; Holly EA; Smith MT
    PLoS One; 2008 Jun; 3(7):e2816. PubMed ID: 18636124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
    Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.